Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acceptance and Commitment Therapy for the Improvement of Cancer Distress in Patients With Incurable Cancers, ACT-C Trial
Sponsor: Mayo Clinic
Summary
This clinical trial studies whether Acceptance and Commitment Therapy can be used to help improve cancer distress for patients with hepatobiliary or breast cancers for which no treatment is currently available (incurable). Patients with hepatobiliary cancer (HBC) and breast cancer often experience high levels of distress and reductions in quality of life. Acceptance and Commitment Therapy for incurable cancers (ACT-C) is a behavioral intervention tailored to patients with incurable HBC and breast cancer. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Official title: Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Incurable Cancers (ACT-C)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-05-28
Completion Date
2027-05-30
Last Updated
2026-08-04
Healthy Volunteers
No
Conditions
Interventions
Acceptance and Commitment Therapy
Attend ACT-C telehealth group sessions
Questionnaire Administration
Ancillary studies
Telemedicine
Attend ACT-C telehealth group sessions
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States